AQR Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-15,685
| Closed | -$75K | – | 2303 |
|
|
2020
Q4 | $75K | Buy |
+15,685
| New | +$75K | ﹤0.01% | 2163 |
|
|
2018
Q4 | – | Sell |
-39,393
| Closed | -$1.16M | – | 2310 |
|
|
2018
Q3 | $1.16M | Hold |
39,393
| – | – | ﹤0.01% | 1651 |
|
|
2018
Q2 | $1.79M | Sell |
39,393
-2,960
| -7% | -$135K | ﹤0.01% | 1472 |
|
|
2018
Q1 | $2.24M | Sell |
42,353
-12,183
| -22% | -$643K | ﹤0.01% | 1307 |
|
|
2017
Q4 | $3.71M | Sell |
54,536
-9,814
| -15% | -$667K | ﹤0.01% | 1135 |
|
|
2017
Q3 | $5.3M | Buy |
64,350
+641
| +1% | +$52.8K | 0.01% | 995 |
|
|
2017
Q2 | $5.97M | Buy |
63,709
+6,727
| +12% | +$630K | 0.01% | 960 |
|
|
2017
Q1 | $3.63M | Buy |
+56,982
| New | +$3.63M | ﹤0.01% | 1143 |
|
|
2016
Q1 | – | Sell |
-17,345
| Closed | -$607K | – | 2307 |
|
|
2015
Q4 | $607K | Buy |
17,345
+10,425
| +151% | +$365K | ﹤0.01% | 1794 |
|
|
2015
Q3 | $636K | Sell |
6,920
-3,705
| -35% | -$341K | ﹤0.01% | 1632 |
|
|
2015
Q2 | $934K | Buy |
+10,625
| New | +$934K | ﹤0.01% | 1520 |
|
|
2014
Q3 | – | Sell |
-11,466
| Closed | -$475K | – | 2613 |
|
|
2014
Q2 | $475K | Sell |
11,466
-21,500
| -65% | -$891K | ﹤0.01% | 2010 |
|
|
2014
Q1 | $2.28M | Buy |
32,966
+5,800
| +21% | +$402K | 0.01% | 1224 |
|
|
2013
Q4 | $1.64M | Buy |
27,166
+529
| +2% | +$31.9K | ﹤0.01% | 1464 |
|
|
2013
Q3 | $1.62M | Sell |
26,637
-88,276
| -77% | -$5.37M | 0.01% | 1409 |
|
|
2013
Q2 | $7.7M | Buy |
+114,913
| New | +$7.7M | 0.03% | 669 |
|